- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Oxford COVID-19 vaccine roll out in UK to start from 4 January: Sunday Telegraph report

London: The United Kingdom will roll out Oxford University's COVID-19 vaccine from Jan. 4, according to plans being drawn up by ministers, The Sunday Telegraph reported.The government hopes to give the first dose of either the Oxford vaccine, which has been licensed to pharmaceuticals company AstraZeneca, or the Pfizer vaccine to 2 million people over the next two weeks, the newspaper...
London: The United Kingdom will roll out Oxford University's COVID-19 vaccine from Jan. 4, according to plans being drawn up by ministers, The Sunday Telegraph reported.
The government hopes to give the first dose of either the Oxford vaccine, which has been licensed to pharmaceuticals company AstraZeneca, or the Pfizer vaccine to 2 million people over the next two weeks, the newspaper said.
Read also: World looking to India for COVID Vaccines: Pharma Experts
The Oxford vaccine is expected to be approved by medical regulators in days, the newspaper said.
Read also: AstraZeneca COVID-19 vaccine likely to get emergency nod by next week in India: Report
M.Com
Ruchika joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751